Skip to main content
Log in

Association of HSP70-hom genetic variant with prostate cancer risk

  • Original Paper
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Because of the importance of androgens to prostate cancer (PCa) development, several candidate genes along androgen pathway have been under intensive study. Given the role of the molecular chaperone HSP70 in the regulation of the androgen receptor (AR) transactivation function, we first chose to explore the association between the HSP70-hom functional genetic variant (+2437 T > C) and prostate cancer risk by genotyping DNA samples from 101 unselected PCa patients and 105 healthy men. There was a trend towards lower frequency of TC and CC genotypes among patients when compared with healthy controls, however the difference did not reach the statistical significance (TC genotype: OR = 0.53, = 0.05; CC genotype: OR = 0.42, = 0.16). Moreover, individuals carrying at least one C allele have a statistically significant lower susceptibility for PCa (OR = 0.51 (0.26–0.97); = 0.02). Since some factors may influence tumor progression rather than initiation, we also examined the relationship between the HSP70-hom polymorphism and the clinical characteristics of the malignancy at the time of diagnosis. The stratified analysis of the genotypes with the clinical stage and tumor grade showed that there was no significant difference in the risk estimates according to prognostic indicators of PCa disease in our population study. This is the first report on the studies of HSP70 SNPs in PCa and our data suggest that this genetic variant may be a genetic marker for PCa susceptibility in Tunisians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. ACS (2004) American Cancer Society 2004, Atlanta

  2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130

    Article  PubMed  Google Scholar 

  3. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78–85

    Article  PubMed  CAS  Google Scholar 

  4. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh PC (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150(3):797–802

    PubMed  CAS  Google Scholar 

  5. Culig Z, Bartsch G, Hobisch A (2002) Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth. Mol Cell Endocrinol 197(1–2):231–238

    Article  PubMed  CAS  Google Scholar 

  6. Marker PC, Donjacour AA, Dahiya R, Cunha GR (2003) Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253(2):165–174

    Article  PubMed  CAS  Google Scholar 

  7. Coffey RN, Watson RW, O’Neill AJ, Mc Eleny K, Fitzpatrick JM (2002) Androgen-mediated resistance to apoptosis. Prostate 53(4):300–309

    Article  PubMed  CAS  Google Scholar 

  8. Kimura K, Markowski M, Bowen C, Gelmann EP (2001) Androgen blocks apoptosis of hormone-dependent prostate cancer cells. Cancer Res 61(14):5611–5618

    PubMed  CAS  Google Scholar 

  9. Grossman ME, Huang H, Tindall DJ (2001) Androgen receptor signalling in androgen refractory prostate cancer. J Natl Cancer Inst 93:1687–1697

    Article  Google Scholar 

  10. Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kallioniemi OP (1997) Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 57:314–319

    PubMed  CAS  Google Scholar 

  11. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9(4):401–406

    Article  PubMed  CAS  Google Scholar 

  12. Miyamoto H, Yeh S, Wilding G, Chang C (1998) Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc Natl Acad Sci U S A 95(13):7379–7384

    Article  PubMed  CAS  Google Scholar 

  13. Froesch BA, Takayama S, Reed JC (1998) BAG-1L protein enhances androgen receptor function. J Biol Chem 273(19):11660–11666

    Article  PubMed  CAS  Google Scholar 

  14. Nollen EA, Kabakov AE, Brunsting JF, Kanon B, Höhfeld J, Kampinga HH (2001) Modulation of in vivo HSP70 chaperone activity by Hip and Bag-1. J Biol Chem 276(7):4677–4682

    Article  PubMed  CAS  Google Scholar 

  15. Knee DA, Froesch BA, Nuber U, Takayama S, Reed JC (2001) Structure-function analysis of Bag1 proteins. Effects on androgen receptor transcriptional activity. J Biol Chem 276(16):12718–12724

    Article  PubMed  CAS  Google Scholar 

  16. Gassler CS, Wiederkehr T, Brehmer D, Bukau B, Mayer MP (2001) Bag-1 M accelerates nucleotide release for human Hsc70 and Hsp70 and can act concentration-dependent as positive and negative cofactor. J Biol Chem 276(35):32538–32544

    Article  PubMed  CAS  Google Scholar 

  17. Shatkina L, Mink S, Rogatsch H, Klocker H, Langer G, Nestl A, Cato AC (2003) The cochaperone Bag-1L enhances androgen receptor action via interaction with the NH2-terminal region of the receptor. Mol Cell Biol 23(20):7189–7197

    Article  PubMed  CAS  Google Scholar 

  18. Guzey M, Takayama S, Reed JC (2000) BAG-1L enhances transactivation function of vitamin D receptor. J Biol Chem 275:40749–40756

    Article  PubMed  CAS  Google Scholar 

  19. Kaur J, Srivastava A, Ralhan R (1998) Expression of 70-kDa heat shock protein in oral lesions: marker of biological stress or pathogenicity. Oral Oncol 34(6):496–501

    Article  PubMed  CAS  Google Scholar 

  20. Wei YQ, Zhao X, Kariya Y, Teshigawara K, Uchida A (1995) Inhibition of proliferation and induction of apoptosis by abrogation of heat-shock protein (HSP) 70 expression in tumor cells. Cancer Immunol Immunother 40(2):73–78

    Article  PubMed  CAS  Google Scholar 

  21. Kaur J, Kaur J, Ralhan R (2000) Induction of apoptosis by abrogation of HSP70 expression in human oral cancer cells. Int J Cancer 85(1):1–5

    Article  PubMed  CAS  Google Scholar 

  22. Zhao ZG, Shen WL (2005) Heat shock protein 70 antisense oligonucleotide inhibits cell growth and induces apoptosis in human gastric cancer cell line SGC-7901. World J Gastroenterol 11(1):73–78

    PubMed  CAS  Google Scholar 

  23. Zhao ZG, Ma QZ, Xu CX (2001) Expression of major heat shock protein 70 in human prostate cancer cell lines PC-3 m and LNCaP and its implication. Clin J Exp Surg 18:169–170

    Google Scholar 

  24. Gibbons NB, Watson RW, Coffey RN, Brady HP, Fitzpatrick JM (2000) Heat-shock proteins inhibit induction of prostate cancer cell apoptosis. Prostate 45(1):58–65

    Article  PubMed  CAS  Google Scholar 

  25. Zhao ZG, Ma QZ, Xu CX (2004) Abrogation of heat-shock protein (HSP)70 expression induced cell growth inhibition and apoptosis in human androgen-independent prostate cancer cell line PC-3 m. Asian J Androl 6(4):319–324

    PubMed  Google Scholar 

  26. Milner CM, Campbell RD (1990) Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 32(4):242–251

    Article  PubMed  CAS  Google Scholar 

  27. Hunt C, Morimoto RI (1985) Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc Natl Acad Sci USA 82(19):6455–6459

    Article  PubMed  CAS  Google Scholar 

  28. Milner CM, Campbell RD (1992) Polymorphic analysis of the three MHC-linked HSP70 genes. Immunogenetics 36(6):357–362

    Article  PubMed  CAS  Google Scholar 

  29. Rippmann F, Taylor WR, Rothbard JB, Green NM (1991) A hypothetical model for the peptide binding domain of hsp70 based on the peptide binding domain of HLA. EMBO J 10(5):1053–1059

    PubMed  CAS  Google Scholar 

  30. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    Article  PubMed  CAS  Google Scholar 

  31. Shields PG, Harris CC (2000) Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18(11):2309–2315

    PubMed  CAS  Google Scholar 

  32. Pociot F, Ronningen KS, Nerup J (1993) Polymorphic analysis of the human MHC-linked heat shock protein 70 (HSP70–2) and HSP70-Hom genes in insulin-dependent diabetes mellitus (IDDM). Scand J Immunol 38(5):491–495

    Article  PubMed  CAS  Google Scholar 

  33. Westman P, Partanen J, Leirisalo-Repo M, Koskimies S (1994) HSP70-Hom NcoI polymorphism and HLA-associations in the Finnish population and in patients with ankylosing spondylitis or reactive arthritis. Eur J Immunogenet 21(2):81–90

    Article  PubMed  CAS  Google Scholar 

  34. Meddeb-Garnaoui A, Gritli S, Garbouj S, Ben Fadhel M, El Kares R, Mansour L, Kaabi B, Chouchane L, Ben Salah A, Dellagi K (2001) Association analysis of HLA-class II and class III gene polymorphisms in the susceptibility to mediterranean visceral leishmaniasis. Hum Immunol 62(5):509–517

    Article  PubMed  CAS  Google Scholar 

  35. Vargas-Alarcon G, Londono JD, Hernandez-Pacheco G, Gamboa R, Castillo E, Pacheco-Tena C, Cardiel MH, Granados J, Burgos-Vargas R (2002) Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies. Ann Rheum Dis 61(1):48–51

    Article  PubMed  CAS  Google Scholar 

  36. Martin AM, Nolan D, Gaudieri S, Almeida CA, Nolan R, James I, Carvalho F, Phillips E, Christiansen FT, Purcell AW, McCluskey J, Mallal S. (2004) Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc Natl Acad Sci U S A 101(12):4180–4185

    Article  PubMed  CAS  Google Scholar 

  37. Bogunia-Kubik K, Lange A (2005) HSP70-hom gene polymorphism in allogeneic hematopoietic stem-cell transplant recipients correlates with the development of acute graft-versus-host disease. Transplantation 79(7):815–820

    Article  PubMed  CAS  Google Scholar 

  38. Zhou F, Wang F, Li F, Yuan J, Zeng H, Wei Q, Tanguay RM, Wu T (2005) Association of hsp70–2 and hsp-hom gene polymorphisms with risk of acute high-altitude illness in a Chinese population. Cell Stress Chaperones 10(4):349–356

    Article  PubMed  CAS  Google Scholar 

  39. Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A (2006) HSP70-hom gene single nucleotide (+2763 G/A and +2437 C/T) polymorphisms in sarcoidosis. Int J Immunogenet 33(2):135–140

    Article  PubMed  CAS  Google Scholar 

  40. Bogunia-Kubik K, Uklejewska A, Dickinson A, Jarvis M, Lange A (2006) HSP70-hom gene polymorphism as a prognostic marker of graft-versus-host disease. Transplantation 82(8):1116–1117

    Article  PubMed  Google Scholar 

  41. Chouchane L, Ahmed SB, Baccouche S, Remadi S. (1997) Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer 80(8):1489–1496

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank all Tunisian subjects for their participation in this study. This work was supported by the ministry of Higher Education and Scientific and Technological Research and the ministry of Public Health of Tunisia. We would like to thank Mr. Adel Rdissi for English revision.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sana Sfar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sfar, S., Saad, H., Mosbah, F. et al. Association of HSP70-hom genetic variant with prostate cancer risk. Mol Biol Rep 35, 459–464 (2008). https://doi.org/10.1007/s11033-007-9107-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-007-9107-1

Keywords

Navigation